ATE342718T1 - Ophthalmische flüssigkeit - Google Patents

Ophthalmische flüssigkeit

Info

Publication number: ATE342718T1
Authority: AT; Austria
Prior art keywords: ophthalmic fluid; tear film; fatty acid; ocular substrate; lipid layer
Prior art date: 1999-08-18

Application number

AT00951121T

Other languages

English (en)

Inventor

Anthony William Sly

Original Assignee

Planned Products Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-18

Filing date

2000-08-16

Publication date

2006-11-15

2000-08-16 Application filed by Planned Products Pty Ltd filed Critical Planned Products Pty Ltd

2006-11-15 Application granted granted Critical

2006-11-15 Publication of ATE342718T1 publication Critical patent/ATE342718T1/de

Links

239000012530 fluid Substances 0.000 title abstract 4
239000000758 substrate Substances 0.000 abstract 3
150000004665 fatty acids Chemical class 0.000 abstract 2
150000002632 lipids Chemical class 0.000 abstract 2
230000001681 protective effect Effects 0.000 abstract 2
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
235000014113 dietary fatty acids Nutrition 0.000 abstract 1
229930195729 fatty acid Natural products 0.000 abstract 1
239000000194 fatty acid Substances 0.000 abstract 1
125000005456 glyceride group Chemical group 0.000 abstract 1
125000005457 triglyceride group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Eyeglasses (AREA)

AT00951121T 1999-08-18 2000-08-16 Ophthalmische flüssigkeit ATE342718T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AUPQ2281A AUPQ228199A0 (en)	1999-08-18	1999-08-18	Ophthalmic fluid

Publications (1)

Publication Number	Publication Date
ATE342718T1 true ATE342718T1 (de)	2006-11-15

Family

ID=3816456

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00951121T ATE342718T1 (de)	1999-08-18	2000-08-16	Ophthalmische flüssigkeit

Country Status (13)

Country	Link
US (2)	US7115667B2 (de)
EP (1)	EP1214068B1 (de)
JP (1)	JP2003506486A (de)
KR (1)	KR100727008B1 (de)
CN (1)	CN1197566C (de)
AT (1)	ATE342718T1 (de)
AU (1)	AUPQ228199A0 (de)
CA (1)	CA2380741A1 (de)
DE (1)	DE60031425D1 (de)
HK (1)	HK1049801B (de)
NZ (1)	NZ517158A (de)
WO (1)	WO2001012179A1 (de)
ZA (1)	ZA200201388B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040076695A1 (en) *	2002-07-08	2004-04-22	Advanced Vision Research	EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US7759507B2 (en) *	2003-09-05	2010-07-20	Abbott Laboratories	Lipid system and methods of use
KR20070001970A (ko) *	2004-02-26	2007-01-04	보오슈 앤드 롬 인코포레이팃드	알기네이트 점탄성 조성물, 사용 방법 및 팩키지
AU2005262392A1 (en)	2004-07-01	2006-01-19	Johnson & Johnson Vision Care, Inc.	Compositions and methods for treating eye disorders and conditions
FR2891187B1 (fr) *	2005-09-29	2010-06-04	Centre Nat Rech Scient	Procede de preparation d'une surface polymere orientee et nanostructuree.
US7670997B2 (en) *	2006-06-08	2010-03-02	Bausch & Lomb Incorporated	Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
US20080166393A1 (en) *	2007-01-05	2008-07-10	Grant Robert K	Eye Medication Delivery System
WO2009005716A1 (en) *	2007-06-29	2009-01-08	The Trustees Of Columbia University In The City Of New York	Utilization of artificial human lipids reconstituted as artificial tears for the stabilization application of ophthalmic therapeutics
TWI506333B (zh)	2008-12-05	2015-11-01	Novartis Ag	用以傳遞疏水性舒適劑之眼用裝置及其製造方法
HK1210417A1 (en) *	2012-07-09	2016-04-22	华柏恩视觉研究中心	Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
US9668996B2 (en)	2014-06-04	2017-06-06	Tersus Life Sciences, LLC	Methods of treating chronic dry eye disease using C16:1n7-palmitoleate and derivatives thereof
DE102019112086B3 (de)	2019-05-09	2020-08-06	Saier Verpackungstechnik Gmbh & Co. Kg	Behälter mit einem von einer Hülle umgebenen Kern
US20240118559A1 (en) *	2022-09-27	2024-04-11	Coopervision International Limited	Sustained release of oleic acid from contact lenses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS608484B2 (ja) *	1979-02-27	1985-03-04	東洋コンタクトレンズ株式会社	コンタクトレンズ用洗浄保存剤
EP0459148B1 (de) *	1990-05-29	1996-01-03	Ocular Research Of Boston Inc.	Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
ZA927277B (en) *	1991-10-02	1993-05-19	Boston Ocular Res	Dry eye treatment process and solution.
EP0656779B1 (de)	1992-08-28	2000-04-12	Pharmos Corporation	Emulsionen im submikron-bereich als vehikel zur arzneistoffverabreichung am auge
US5474979A (en)	1994-05-17	1995-12-12	Allergan, Inc.	Nonirritating emulsions for sensitive tissue
DE19511322C2 (de)	1995-03-28	1999-09-02	Mann Gerhard Chem Pharm Fab	Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
WO1998016217A1 (en) *	1996-10-17	1998-04-23	Isaacs Charles E	Disinfecting contact lenses
US5981607A (en) *	1998-01-20	1999-11-09	Allergan	Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers

1999
- 1999-08-18 AU AUPQ2281A patent/AUPQ228199A0/en not_active Abandoned
2000
- 2000-08-16 JP JP2001516525A patent/JP2003506486A/ja active Pending
- 2000-08-16 CA CA002380741A patent/CA2380741A1/en not_active Abandoned
- 2000-08-16 NZ NZ517158A patent/NZ517158A/en unknown
- 2000-08-16 DE DE60031425T patent/DE60031425D1/de not_active Expired - Lifetime
- 2000-08-16 CN CNB008127204A patent/CN1197566C/zh not_active Expired - Fee Related
- 2000-08-16 HK HK03102082.2A patent/HK1049801B/zh not_active IP Right Cessation
- 2000-08-16 WO PCT/AU2000/000977 patent/WO2001012179A1/en not_active Ceased
- 2000-08-16 EP EP00951121A patent/EP1214068B1/de not_active Expired - Lifetime
- 2000-08-16 AT AT00951121T patent/ATE342718T1/de not_active IP Right Cessation
- 2000-08-16 KR KR1020027002084A patent/KR100727008B1/ko not_active Expired - Fee Related
2002
- 2002-02-19 ZA ZA200201388A patent/ZA200201388B/xx unknown
2004
- 2004-02-18 US US10/781,179 patent/US7115667B2/en not_active Expired - Fee Related
2006
- 2006-09-29 US US11/537,314 patent/US20070021503A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2001012179A1 (en)	2001-02-22
EP1214068A1 (de)	2002-06-19
US20070021503A1 (en)	2007-01-25
ZA200201388B (en)	2003-05-28
DE60031425D1 (de)	2006-11-30
KR100727008B1 (ko)	2007-06-14
CN1197566C (zh)	2005-04-20
US7115667B2 (en)	2006-10-03
HK1049801B (zh)	2005-12-02
JP2003506486A (ja)	2003-02-18
AUPQ228199A0 (en)	1999-09-09
KR20020050228A (ko)	2002-06-26
CA2380741A1 (en)	2001-02-22
NZ517158A (en)	2003-10-31
EP1214068B1 (de)	2006-10-18
HK1049801A1 (en)	2003-05-30
CN1373661A (zh)	2002-10-09
US20040167218A1 (en)	2004-08-26
EP1214068A4 (de)	2004-05-12

Legal Events

Date	Code	Title	Description
2007-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE342718T1 (de)	2006-11-15	Ophthalmische flüssigkeit
DE59808773D1 (de)	2003-07-24	Verwendung synthetischer Triglyceride auf Basis konjugierter Linolsäure zur Herstellung von Mitteln zur Behandlung von katabolischen Zuständen
ES2109645T3 (es)	1998-01-16	Lente de contacto multifocal.
WO2004085582A3 (en)	2004-12-02	Lipid-improving agent and composition containing lipid-improving agent
MY128021A (en)	2007-01-31	Sheet with oil ingredient-containing layer
TR199701276T1 (xx)	1998-02-21	Biyoaktif bile�ikler olarak 1,3-propan diol t�revleri.
PL346149A1 (en)	2002-01-28	Amphoteric derivatives of aliphatic polyamines with fatty acids, esters or triglycerides
ATE203911T1 (de)	2001-08-15	Tränendrüsen spezifische emulsion zur topischen anwendung an okulären geweben
ATE478129T1 (de)	2010-09-15	Kerzenwachs auf triacylglycerin-basis
DK0464084T3 (da)	1997-08-11	Anvendelse af eicosapentaensyre til behandling af kakeksi
ID17466A (id)	1998-01-08	Proses pembuatan asam dokosaheksanoat dan asam dokosapentanoat
DK1152755T3 (da)	2002-07-22	Essentielle fedtsyrer til forebyggelse af cardiovaskulære tilfælde
NO920604L (no)	1992-02-14	Fremgangsmaate for fremstilling av naeringsmiddelinneholdende kapsler
FI963867A7 (fi)	1996-11-27	Rasvahappoestereiden käyttö bioadhesiivisina aineina
TR199701098T1 (xx)	1998-02-21	Trigliserid ya�lar�n�n fraksiyonlanmas�.
ATE154205T1 (de)	1997-06-15	Nährfette mit verbesserter verdaulichkeit
UY26303A1 (es)	2001-03-16	Composiciones farmacéuticas para administración oral y tópica
ES2143067T3 (es)	2000-05-01	Procedimiento para la preparacion de esteres acrilicos refinados.
DK0745116T3 (da)	1999-08-02	Hærdning af umættede fedtstoffer, fedtsyrer eller fedtsyreestere
JP2003506486A5 (de)	2007-09-06
DE69302910D1 (de)	1996-07-04	Triglyceride-zusammensetzungen gegen fettbleichen
DE60323520D1 (de)	2008-10-23	Dreischichtige tränenformulierung
ATE399001T1 (de)	2008-07-15	Sphäroide, deren herstellungsverfahren und sphäroidenhaltige arzneimittel
JPS5791913A (en)	1982-06-08	Pharmaceutical preparation of drug
OA06038A (fr)	1980-06-30	Procédé de préparation de nitriles d'acides gras et de glycérol à partir de glycérides en particulier à partir de graisses et huiles naturelles.